# Openwater Commons Roadmap

**Last Updated:** December 2025  
**Status:** Active Development

---

## ðŸŽ¯ Vision

Transform Openwater into the "Linux of medical devices" - a global open-source platform enabling hundreds of developers to build diagnostic and therapeutic medical devices at 10-100x lower cost than traditional approaches.

---

## 2025 Q4 (Oct-Dec) - Foundation

### âœ… Completed
- [x] Established openwater-commons repository
- [x] Created governance framework
- [x] Defined community guidelines

### ðŸ”„ In Progress
- [ ] Organization restructuring (Week 1 of 12)
- [ ] License transition planning (AGPL â†’ Apache 2.0)
- [ ] Community infrastructure buildout
- [ ] Documentation site setup

### ðŸŽ¯ Goals
- Professional GitHub organization structure
- Clear contribution pathways
- Transparent governance model
- Foundation for community growth

---

## 2026 Q1 (Jan-Mar) - Community Launch

### Infrastructure (Month 1)
- [ ] Complete GitHub organization transformation
  - `.github` repository with org-wide files
  - `openwater-docs` documentation site
  - `awesome-openwater` curated resources
- [ ] Execute Apache 2.0 license transition
  - Update all software/firmware repos
  - CERN-OHL-P for hardware repos
  - CLA implementation
- [ ] Resubmit SlicerOpenLIFU to 3D Slicer community
- [ ] Launch community Discord/forum

### Platform Restructuring (Month 2-3)
- [ ] **OpenLIFU Hardware Separation**
  - Create `OpenLIFU-hardware-mechanical` (Pete's CAD files)
  - Create `OpenLIFU-hardware-electrical` (schematics, PCBs)
  - Create `OpenLIFU-bom` (bill of materials)
  - Create `OpenLIFU-assembly-guides` (assembly documentation)
  - Archive `opw_neuromod_hw` with clear migration
- [ ] **OpenMOTION Hardware Separation**
  - Same structure as OpenLIFU
  - Motion sensor hardware
  - Console hardware
  - Laser integration
- [ ] Cross-link all repos for easy navigation

### Academic Partnerships (Month 1-3)
- [ ] Mayo Clinic: Expand $200K pilot
- [ ] Stanford: Research licensing agreement
- [ ] Johns Hopkins: Neuroscience collaboration
- [ ] 2-3 signed research partnerships ($50K+ committed)

### Community Growth
- [ ] 50+ active community members
- [ ] 15+ meaningful contributions (PRs, issues, docs)
- [ ] Monthly community office hours established
- [ ] First community showcase project

**Q1 Target:** $500K+ in committed revenue pipeline, 50+ contributors

---

## 2026 Q2 (Apr-Jun) - Revenue & Growth

### Revenue Acceleration
- [ ] Close 2-3 academic licensing agreements ($50K-$75K)
- [ ] Pharma data partnership discussions (Pfizer, Novartis, Roche)
- [ ] First enterprise healthcare pilot (post-FDA if approved)
- [ ] Commercial device manufacturer partnerships (Medtronic, Abbott)

### Community Expansion
- [ ] 150+ active community members
- [ ] 50+ meaningful contributions
- [ ] Launch Community Grants Program ($50K pool)
- [ ] First in-person Openwater Developer Summit
- [ ] Community Advisory Board established (5-7 members)

### Product Development
- [ ] Open-LIFU 2.0: QMS builds ship
- [ ] Open-Motion 3.0: EVT builds complete
- [ ] Documentation site fully populated
- [ ] Example projects and tutorials launched
- [ ] Hardware fabrication guides with photos/videos

### Conference Presence
- [ ] SPIE Medical Imaging (February) - Speaking slot
- [ ] HIMSS Global Health (February) - Presentation
- [ ] ISMRM (May) - Full presentation + poster
- [ ] Red Hat Summit (May) - Open-source business model learning

**Q2 Target:** $250K closed revenue, 150+ contributors, professional conference presence

---

## 2026 Q3 (Jul-Sep) - Scale & Ecosystem

### Revenue Scale
- [ ] $500K cumulative closed revenue
- [ ] 1-2 enterprise health system deals ($150K-$300K each)
- [ ] 2-3 active pharma partnerships
- [ ] First commercial device manufacturer licensing deal

### Community Maturity
- [ ] 300+ active community members
- [ ] 100+ meaningful contributions
- [ ] 3-5 community "showcase" applications
- [ ] International community chapters (Europe, Asia)
- [ ] "Openwater Certified Developer" program launch

### Platform Evolution
- [ ] FDA submission progress (if applicable)
- [ ] CE marking exploration (European market)
- [ ] Cloud services strategy implementation
- [ ] Advanced hardware-software integration examples
- [ ] Automated CI/CD for hardware validation

### Developer Ecosystem
- [ ] Developer Advocate hire #2
- [ ] Regional community meetups (SF, Boston, NYC)
- [ ] University curriculum integration (3-5 schools)
- [ ] Bounty program launched ($25K pool)

**Q3 Target:** $500K cumulative revenue, 300+ contributors, ecosystem maturity

---

## 2026 Q4 (Oct-Dec) - Enterprise & Sustainability

### Revenue Sustainability
- [ ] $1M+ cumulative closed revenue
- [ ] 3-5 enterprise health system deals
- [ ] 5+ pharma partnerships active
- [ ] 2-3 device manufacturer licensing agreements
- [ ] Series A fundraising preparation

### Community Leadership
- [ ] 500+ active community members (on track for "hundreds")
- [ ] 200+ meaningful contributions
- [ ] Annual Openwater Summit (200+ attendees)
- [ ] Community-led innovation generating commercial opportunities
- [ ] Consider Openwater Foundation (separate non-profit entity)

### International Expansion
- [ ] European market entry (CE marking if complete)
- [ ] Asia-Pacific partnerships
- [ ] International manufacturing relationships
- [ ] Global community presence

### Platform Maturity
- [ ] Stable OpenLIFU 2.0 platform
- [ ] Stable OpenMOTION 3.0 platform
- [ ] Comprehensive documentation
- [ ] Mature governance model
- [ ] Sustainable open-source business model

**Q4 Target:** $1M+ revenue, 500+ contributors, sustainable ecosystem

---

## Long-Term Vision (2027+)

### 2027 Goals
- **Community:** 1,000+ active developers globally
- **Revenue:** $5M+ annual revenue from services, partnerships, licensing
- **Clinical Translation:** Multiple FDA-cleared devices
- **Global Impact:** Deployments in 10+ countries
- **Ecosystem:** 50+ derivative products and services

### 2028 Goals
- **Community:** 5,000+ active developers
- **Revenue:** $20M+ annual revenue
- **Impact:** Reaching 100,000+ patients through open-source platforms
- **Model:** Proven open-source medical device business model
- **Legacy:** "The Linux of medical devices" - widely recognized standard

---

## Key Metrics & Success Indicators

### Community Health
- **Active Contributors:** Growing 20% quarter-over-quarter
- **Contribution Quality:** 15+ meaningful PRs per month
- **Retention:** 50%+ contributor retention after first contribution
- **Geographic Diversity:** Contributors from 20+ countries

### Business Health
- **Revenue Pipeline:** $500K+ committed opportunities
- **Partnership Quality:** 10+ active research/commercial partnerships
- **Customer Retention:** 90%+ renewal rate
- **Cost Efficiency:** 10-100x lower than traditional approaches

### Platform Health
- **Repository Activity:** 100+ stars, 50+ forks on key repos
- **Documentation Quality:** <5% "needs improvement" feedback
- **Issue Response Time:** <48 hours for community questions
- **Hardware Reproducibility:** 90%+ success rate for community builds

### Impact Metrics
- **Research Publications:** 10+ papers using Openwater platforms
- **Clinical Trials:** 5+ trials using open-source platforms
- **Derivative Projects:** 20+ community-led applications
- **Regulatory Approvals:** 3+ FDA clearances using platform

---

## Strategic Priorities

### 1. Permissive Licensing (Critical Path)
**Why:** AGPL blocks clinical translation and academic partnerships  
**Action:** Transition to Apache 2.0 (software) + CERN-OHL-P (hardware)  
**Timeline:** Q1 2026  
**Evidence:** 3D Slicer rejection documented

### 2. Hardware Accessibility
**Why:** Scattered CAD files block community hardware development  
**Action:** Separate mechanical/electrical, add BOMs, assembly guides  
**Timeline:** Q1-Q2 2026  
**Impact:** Enable reproducible community builds

### 3. Community First
**Why:** "Hundreds of developers" is CEO Priority #4  
**Action:** Professional infrastructure, clear pathways, recognition  
**Timeline:** Ongoing throughout 2026  
**Target:** 500+ contributors by end of 2026

### 4. Revenue Diversification
**Why:** "Revenue beyond hardware" is CEO Priority #3  
**Action:** Research licensing, pharma partnerships, enterprise SaaS  
**Timeline:** Q1-Q4 2026  
**Target:** $1M+ from non-hardware sources

### 5. Clinical Translation
**Why:** Open-source enabling real healthcare impact  
**Action:** FDA submissions, CE marking, clinical trials support  
**Timeline:** Q2-Q4 2026  
**Impact:** First open-source medical devices reaching patients

---

## Risks & Mitigations

### Risk: FDA Delays
**Impact:** Delays enterprise healthcare revenue  
**Mitigation:** Focus on research licensing and pharma partnerships (non-FDA)  
**Contingency:** Accelerate European CE marking path

### Risk: Slow Community Adoption
**Impact:** Missing "hundreds of developers" goal  
**Mitigation:** Developer Advocate hire, showcase projects, bounties  
**Contingency:** Increase incentives, partner with universities

### Risk: License Transition Resistance
**Impact:** Community confusion or pushback  
**Mitigation:** Clear communication, 3D Slicer evidence, CLA process  
**Contingency:** Extended transition period, 1:1 contributor support

### Risk: Hardware Reproduction Challenges
**Impact:** Community can't build devices  
**Mitigation:** Comprehensive BOMs, assembly guides, supplier info  
**Contingency:** Hardware workshops, maker space partnerships

### Risk: Competitive Response
**Impact:** Traditional vendors counter with open offerings  
**Mitigation:** First-mover advantage, network effects, quality focus  
**Contingency:** Differentiate on community, speed, cost

---

## How to Contribute to This Roadmap

**This roadmap is community-driven. You can:**

1. **Propose additions:** Open an issue or RFC
2. **Offer expertise:** Join working groups for specific initiatives
3. **Track progress:** Follow project boards for each quarter
4. **Provide feedback:** Monthly community calls for roadmap review

**Roadmap updates:** Reviewed monthly by TSC, updated quarterly

---

## Contact & Coordination

- **Roadmap Owner:** Director of Open-Source Business Strategy
- **TSC Review:** First Monday of each month
- **Community Input:** Monthly community calls
- **Questions:** [Open an issue](https://github.com/OpenwaterHealth/openwater-commons/issues) with "roadmap" label

---

**Making advanced medical technology accessible to everyone, everywhere.** ðŸŒ
